Loading clinical trials...
Loading clinical trials...
Pancreatic radiofrequency ablation (RFA) could therefore be an alternative to the monitoring of pancreatic neuroendocrine tumors (PNETs) and more particularly nonfunctioning PNETs (NF-PNETs), which is...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Institut Paoli-Calmettes
NCT04464122 · Neuroendocrine Tumors, Neuroendocrine Neoplasm, and more
NCT06855095 · Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, and more
NCT06472388 · Neuroendocrine Tumors, Progression, and more
NCT06148636 · Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, and more
Institut Paoli Calmettes
Marseille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions